Oncology

Weighing Relapse Risk Against Benefit in Advanced NSCLC Immunotherapy: Jonathan Thompson, MD, MS

CAR T and Bispecifics Pose Different Challenges in Blood Cancer Treatment: Ravi Vij, MD, MBA

Navigating Perioperative Immunotherapy Decisions in Lung Cancer Care: Jonathan Thompson, MD, MS

Refining Treatment Timelines and Immunotherapy Strategies in Early-Stage NSCLC: Jonathan Thompson, MD, MS

Operational Challenges and Collaborative Solutions in Cell and Gene Therapy Implementation at UC Davis Health: Jenny Craven, PharmD, BCPS

Expanding the Role of NGS and Retesting in Early and Refractory NSCLC: Jonathan Thompson, MD, MS

Outpatient Models Boost Cost-Effectiveness of CAR T and Bispecific Therapy in Multiple Myeloma: Emilie Aschenbrenner, PharmD, BCOP

Embedding Reflex Biomarker Testing to Advance Precision Lung Cancer Care: Jonathan Thompson, MD, MS

Pharmacists Leading the Charge in Real-World Evidence–Driven Contracting: Clayton Irvine, PharmD, MBA, MS

Balancing Efficacy, Safety, and Cost in Formulary Decisions for Cell and Gene Therapies: Clayton Irvine, PharmD, MBA, MS

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions

Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic

Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman

Oncology Onward: A Conversation With OneOncology’s Dr Jeff Patton

Health Equity Conversations: Improving Diversity of Oncology Care Staff

Lymphoma Research Foundation CEO on Biden’s Cancer Moonshot, Financial Toxicity

Reforming Oncology Care Payments: Interviews From the QCCA Leadership Summit

What Are the Next Steps for Collaboration, Accountability in Oncology Care First?

KOL Corner: Amy Ellis Discusses Value-Based Cancer Rehab With Amanda Hodges